Lilly Medical Affairs
Developed under the direction and sponsorship of Lilly Medical Affairs and is intended for US healthcare professionals only.
Video Player is loading.
Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and Sequencing
By
Lilly Medical Affairs
FEATURING
Joyce O’Shaughnessy
By
Lilly Medical Affairs
FEATURING
Joyce O’Shaughnessy
In this video, Dr. Joyce O’Shaughnessy discusses the treatment landscape for patients who progress on ET + CDK4/6 inhibitors, including the importance of biomarker testing in this setting.
To access additional videos and download free resources, click here.
VV-OTHR-US-DEL-3129 © 2024 Lilly USA, LLC. All Rights Reserved.
Comments are disabled for this content.
